Sarah Miller
Psychiatric/Mental Health · Trinity, FLNPI 1336786714
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,424 and has fallen 86.3% since, to $195 in 2025.
Across 98 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$274
- Alkermes, Inc.$187
- Johnson & Johnson$184
- AbbVie$180
- Teva Pharmaceuticals USA, Inc.$152
- Sunovion Pharmaceuticals Inc.$100
- plus $701 from 14 others
What the payments were for
- Food & beverage$1,72997%
- Education$473%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $274 |
| Alkermes, Inc. | 8 | $187 |
| Johnson & Johnson | 11 | $184 |
| AbbVie(2 entities) | 12 | $180 |
| Teva Pharmaceuticals USA, Inc. | 10 | $152 |
| Sunovion Pharmaceuticals Inc. | 6 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $99 |
| Eisai Inc. | 6 | $90 |
| Vanda Pharmaceuticals Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Avanir Pharmaceuticals, Inc. | 3 | $65 |
| Jazz Pharmaceuticals Inc. | 3 | $59 |
| Bausch Health US, LLC | 3 | $48 |
| Indivior Inc. | 2 | $38 |
| Lundbeck LLC | 2 | $32 |
| Merck | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Neos Therapeutics, LP | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $14 |
How this compares
$1,776 in reported general payments places this provider in the 70th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 15 | $553 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $311 |
| Donepezil Hcl | 15 | $129 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $56 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Trinity
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
- Carolann BrooksCelebration$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.